E-cards may be grabbing share from traditional cards, but consumers who purchase paper cards are gravitating toward higher-priced products. Greeting cards that feature such technological elements as recording features and LED lights, cards from recycled materials and specialty cards, such as those featuring decorative elements, will continue to buoy profit margins in the category.
More and more cough-cold retailers are pulling their circular ad placements out of the back-to-school season and focusing their efforts on placement closer to an uptick in cough-cold demand, according to a recent ECRM webcast hosted by Drug Store News titled “Surviving the Cough-Cold Season: A Category Promotion Review.”
Only 18% of Americans were very likely or completely likely to post their latest ailment on social media, but for those who did post, 40% of their friends were quick to make an over-the-counter recommendation, according to a survey conducted in July by Field Agent on behalf of Drug Store News. And about half the time, those who posted that they were under the weather listened to their friends’ recommendations and made a purchase as a result.
Cosmederm Bioscience’s Tri-Calm OTC itch relief solution is quickly climbing the anti-itch treatment product chart with growth of 148.2% to a dollar base of $4.9 million for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI.
Addressing everything from minor cuts and abrasions to skin rashes and muscle aches, the first aid category is doing well — sales of first-aid treatments are up 5.5% to $1.4 billion for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI, and the larger accessories category — including heat/ice packs — is up 7.2% to $1.8 billion.
When Procter & Gamble line extended its NyQuil brand identity into the sleep care aisle with the launch of ZzzQuil, the company did more than raise a few eyebrows. That launch awoke an entire category.
Sleeping remedy sales reached $446.3 million on 6.5% growth for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI. And while the products sold may help consumers sleep at night, the category still is contributing a steady flow of dollars to OTC coffers.
Overall, there were $8.7 billion in sales of cough, cold and allergy products for the 52 weeks ended June 14 across U.S. multi-outlets, according to IRI, and allergy remedies are driving that sales bus.